Publications
5808 Results
- Journal / Conference
- International Melanoma Congress, abstract 50; 8th Annual Meeting, Nov 9-11, 2011, Tampa, Fl; oral presentation
- Year
- 2011
- Research Committee(s)
- Melanoma
- Study Number(s)
- S0026, S0438, S0508, S0512, S0826
Benchmarks for evaluating phase II clinical trials in stage IV melanoma: the recent SWOG experience
- Journal / Conference
- Blood 118(21):abst 3955; American Society of Hematolgy, poster presentation
- Year
- 2011
- Research Committee(s)
- Myeloma
- Study Number(s)
- S0120
SWOG S0120 observational trial for MGUS and asymptomatic multiple myeloma (AMM): imaging predictors of progression for patients treated at UAMS
- Journal / Conference
- Journal of Clinical Oncology 29:(suppl; abstr 4514); ASCO oral presentation
- Year
- 2011
- Research Committee(s)
- Genitourinary
- Study Number(s)
- JPR7
A phase III randomized trial of intermittent versus continuous androgen suppression for PSA progression after radical therapy (NCIC CTG PR.7/SWOG JPR.7/CTSU JPR.7/UK intercontinental trial CRUKE/01/013
- Journal / Conference
- Journal of Clinical Oncology 29:(suppl 4: abstr 2); ASCO oral presentation
- Year
- 2011
- Research Committee(s)
- Lung
Systemic evaluation of the impact of disease progression (DP) date determination on progression-free survival (PFS) in advanced lung cancer: a joint North Central Cancer Treatment Group (NCCTG) and Southwest Oncology Group (SWOG) investigation
- Journal / Conference
- International Conference on Malignant Lymphoma, 11th annual meeting, oral presentation
- Year
- 2011
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S0350
Phase II trial of cisplatin plus etoposide plus gemcitabine plus solumedrol (PEGS) in peripheral T-cell non-Hodgkin lymphoma (SWOG S0350)
- Journal / Conference
- Journal of Clinical Oncology, 29(33):4417-23;
- Year
- 2011
- Research Committee(s)
- Leukemia
- PMID
- PMID21969499
- PMC
- PMC3221524
- Study Number(s)
- S0106, SWOG-8600, SWOG-9031, SWOG-9034 (EST-3489) (CALGB-9120), SWOG-9126, SWOG-9333, SWOG-9500, S9617, S9918
Prediction of early death following induction therapy for newly diagnosed acute leukemia with pretreatment risk scores: a novel paradigm for treatment assignment
- Journal / Conference
- Blood 118(21):abstract 430; American Society of Hematology Annual Meeting, oral presentation;
- Year
- 2011
- Research Committee(s)
- Lymphoma
- Study Number(s)
- E2496
A gene expression signature in diagnostic formalin fixed paraffin embedded tissue predicts overall survival in locally advanced and advanced stage classical hodgkin lymphoma - a correlative study from the E2496 intergroup trial
- Journal / Conference
- Blood 118(21):abstract 87; American Society of Hematology Annual Meeting, oral presentation
- Year
- 2011
- Research Committee(s)
- Lymphoma
- Study Number(s)
- E4494
Gene risk scores based on expression of 6 genes quantitated by nuclease protein assay in formalin fixed paraffin-embedded DLBCL specimens from CHOP and RCHOP treated patients predicts outcome: an ECOG and SWOG study
- Journal / Conference
- International Journal of Radiation Oncology, Biology & Physics 79(2):481-489
- Year
- 2011
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID20400244
- PMC
- PMC2929319
- Study Number(s)
- S0713
Prospective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group setting [PMID20400244; PMC2929319]
- Journal / Conference
- Journal of Clinical Oncology 29(34):4491-4497
- Year
- 2011
- Research Committee(s)
- Breast
- Study Number(s)
- N9831